Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for May, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- Spotlight on Market and Fed Exit Plan
- This Week's Top Value Stocks
- Anatomy of Success: National Retail Properties
- RTI: Buy or Sell: Bank of America (BAC)
- The Best ETF to Play Japan's Surge
- Roundtable Top Picks of the Week
- Top-Rated Zacks Rank Sectors
- Double-Down on These Gaming Stocks
- Railroad Industry Stock Outlook - May 2013
- AWS 5/14: Thinking of Life Without QE
- PFP 5/14: This Is Getting Too Easy
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/14/2013
| Company Name | Symbol | %Change |
|---|---|---|
| INTEROIL COR | IOC | 9.57% |
| INFORMATION | III | 9.47% |
| A M R CP | AAMRQ | 6.83% |
| SCIENTIFIC L | SCIL | 5.26% |
| PACER INTL I | PACR | 5.23% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
On May 13, we downgraded Health Management Associates Inc. ( HMA - Analyst Report ) to Underperform based on its first quarter 2013 results.
On May 2, Health Management announced results for the reported quarter. Earnings per share of 13 cents matched the Zacks Consensus Estimate. However, net income at Health Management decreased 38.7% year over year to $23.1 million (or 9 cents per share).
Revenues (prior to provisioning for doubtful clients) increased about 2.2% year over year to $1,723.8 million, missing the Zacks Consensus Estimate of $1,744 million. Net revenues from same hospital decreased 1% to $1,470 million. Same hospital admissions and adjusted admissions dipped 8.8% and 5.8%, respectively, while surgeries and emergency room visits decreased 5.6% and increased 1%, respectively.
A rise in observation stay was a factor in the drop of same hospital admissions. Many hospitals in Florida are seeing heightened pressure from payers to put patients under observation. Overall observation stays moved up 14.1% year over year in the first quarter 2013.
Total uncompensated care (the sum of uninsured discounts, charity/indigent write-offs, and bad debt expense as a percentage of adjusted revenue) was on the higher side at 28.6% in first-quarter 2013, up from 26.1% in the prior-year quarter. Bad debt expense was 14% of revenues in the first quarter 2013, higher than 11.9% in the year-ago quarter.
Health Management tightened its guidance range for earnings per share from 86 cents to $1.01 to 86 cents to 95 cents for 2013.
The Zacks Consensus Estimate for 2013 has dropped 4.3% to 88 cents over the last 30 days. It has declined 6.4% to $1.03 for 2014 over the same timeframe.
We currently have a Zacks Rank #5 (Strong Sell) on Health Management. We are more positive about Acadia Healthcare Company, Inc. ( ACHC - Snapshot Report ) , which carries a Zacks Rank #2 (Buy). Intuitive Surgical, Inc. ( ISRG - Analyst Report ) and HeartWare International Inc. ( HTWR - Snapshot Report ) are two other Zacks Rank #2 (Buy) stocks, which are expected to do well.
Read the full reports :
Analyst Report on ISRG
Analyst Report on HMA
Snapshot Report on HTWR
Snapshot Report on ACHC